Related Experiment Video
Updated: Apr 25, 2026

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
Review of the molecular pathogenesis of osteosarcoma
Jin-Peng He1, Yun Hao, Xiao-Lin Wang
1Pediatric Surgery Department, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China E-mail : olang@foxmail.com, hejinpeng2006@126.com.
Abstract:
Treating the osteosarcoma (OSA) remains a challenge. Current strategies focus on the primary tumor and have limited efficacy for metastatic OSA. A better understanding of the OSA pathogenesis may provide a rational basis for innovative treatment strategies especially for metastases. The aim of this review is to give an overview of the molecular mechanisms of OSA tumorigenesis, OSA cell proliferation, apoptosis, migration, and chemotherapy resistance, and how improved understanding might contribute to designing a better treatment target for OSA.
Insights
Osteosarcoma (OSA) treatment is challenging, especially for metastatic cases. Understanding OSA
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Osteosarcoma (OSA) presents significant treatment challenges, particularly for metastatic disease.
- Current therapeutic strategies primarily target the primary tumor, showing limited effectiveness against widespread OSA.
- A deeper comprehension of OSA's molecular underpinnings is crucial for developing novel treatments.
Purpose of the Study:
- To review the molecular mechanisms driving osteosarcoma (OSA) tumorigenesis.
- To explore the molecular pathways involved in OSA cell proliferation, apoptosis, migration, and chemotherapy resistance.
- To identify potential therapeutic targets for OSA based on a comprehensive understanding of its pathogenesis.
Main Methods:
- Literature review of molecular mechanisms in osteosarcoma (OSA).
- Analysis of studies on OSA cell proliferation, apoptosis, migration, and drug resistance.
- Synthesis of current knowledge on OSA pathogenesis and therapeutic targets.
Main Results:
- Detailed overview of molecular mechanisms in osteosarcoma (OSA) development and progression.
- Identification of key pathways regulating OSA cell behavior and treatment response.
- Highlighting the need for targeted therapies addressing metastatic OSA.
Conclusions:
- A thorough understanding of osteosarcoma (OSA) molecular pathogenesis is essential for advancing treatment strategies.
- Targeting specific molecular pathways offers promise for improving outcomes in metastatic OSA.
- Further research into OSA's molecular biology can guide the development of more effective therapies.
More Related Videos
04:25Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...